Skip to content

Clinical trials

Phase 1/2 Lymphoma, T-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 1/2 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20102
20111
20121
20132
20152
20163
20175
20182
20193
20202
20212
20222
20231
20242
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting12
Active, not recruiting4
Unknown status4
Not yet recruiting2
Suspended2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Beijing GoBroad Hospital2
City of Hope Medical Center2
Fred Hutchinson Cancer Center2
National Cancer Institute (NCI)2
AIDS Malignancy Consortium1
Acrotech Biopharma Inc.1
Ahmed Sawas1
Alexion Pharmaceuticals, Inc.1
Autolus Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell41
Immunoblastic Lymphadenopathy10
Lymphoma, Large-Cell, Anaplastic10
Lymphoma, T-Cell, Cutaneous9
Hodgkin Disease8
Lymphoma, B-Cell8
Mycosis Fungoides7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma7
Lymphoma6
Lymphoma, Follicular6

Trials

Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.